Back to Journals » Cancer Management and Research » Volume 14

WFDC2 Contributes to Epithelial–Mesenchymal Transition (EMT) by Activating AKT Signaling Pathway and Regulating MMP-2 Expression [Retraction]

Authors Chen Y, Huang L, Wang S, Li JL, Li M, Wu Y, Liu T

Received 23 March 2022

Accepted for publication 23 March 2022

Published 20 April 2022 Volume 2022:14 Pages 1471—1472

DOI https://doi.org/10.2147/CMAR.S367649



Chen Y, Huang L, Wang S, et al. Cancer Manag Res. 2019;11:2415-2424

At the authors request, the Editor and Publisher of Cancer Management and Research wish to retract the published article. The authors have informed the journal that they have concerns regarding the reliability of the published Western blot results and cannot locate or provide any original Western blot data relating to their study. The authors can no longer verify the findings as reported and the Editor has agreed with the request to retract the article.

Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

This retraction relates to this paper

Creative Commons License © 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.